Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour

[1]  A. Toland,et al.  The role of parental and grandparental epigenetic alterations in familial cancer risk. , 2008, Cancer research.

[2]  G. Hoff,et al.  Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma , 2007, BMC Cancer.

[3]  Hua Han,et al.  Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. , 2007, Biochemical and biophysical research communications.

[4]  R. Jirtle,et al.  Epigenetic Gene Regulation: Linking Early Developmental Environment to Adult Disease , 2006 .

[5]  Hua Han,et al.  The Repression of Human Differentiation-related Gene NDRG2 Expression by Myc via Miz-1-dependent Interaction with the NDRG2 Core Promoter* , 2006, Journal of Biological Chemistry.

[6]  Graziano Pesole,et al.  On the statistical assessment of classifiers using DNA microarray data , 2006, BMC Bioinformatics.

[7]  Manel Esteller,et al.  The necessity of a human epigenome project. , 2006, Carcinogenesis.

[8]  W. Coleman,et al.  Quantitative DNA methylation analysis: the promise of high-throughput epigenomic diagnostic testing in human neoplastic disease. , 2006, The Journal of molecular diagnostics : JMD.

[9]  M. Young,et al.  Mechanisms of Mineralocorticoid Action , 2005, Hypertension.

[10]  Arie Perry,et al.  Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. , 2005, Cancer research.

[11]  T. DeWeese,et al.  Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. , 2005, Cancer research.

[12]  Katrin Hoffmann,et al.  Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR – how well do they correlate? , 2005, BMC Genomics.

[13]  Hans Clevers,et al.  Self-Renewal and Cancer of the Gut: Two Sides of a Coin , 2005, Science.

[14]  W. Kolch,et al.  Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. , 2005, Cancer research.

[15]  M. Somerfield,et al.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Corthals,et al.  Akt Mediates Insulin-stimulated Phosphorylation of Ndrg2 , 2004, Journal of Biological Chemistry.

[17]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[18]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[19]  Kwang Dong Kim,et al.  Expression and regulation of NDRG2 (N‐myc downstream regulated gene 2) during the differentiation of dendritic cells , 2003, FEBS letters.

[20]  S. Leung,et al.  N‐Myc downstream‐regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation , 2003, International journal of cancer.

[21]  M. Esteller.  Relevance of DNA methylation in the management of cancer. , 2003, The Lancet. Oncology.

[22]  S. Toyooka,et al.  Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. , 2002, Cancer research.

[23]  A. Kaneda,et al.  Identification of silencing of nine genes in human gastric cancers. , 2002, Cancer research.

[24]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[25]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[26]  T. Miyata,et al.  Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. , 2001, Genomics.

[27]  D. Chung,et al.  The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. , 2000, Gastroenterology.

[28]  M. Waye,et al.  Modulation of the Ca2+-Activated Cl− Channel by 14-3-3ε , 2000 .

[29]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[30]  Peter A. Jones,et al.  Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands , 1999, Molecular and Cellular Biology.

[31]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[32]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Lloyd D. Fisher,et al.  2. Biostatistics: A Methodology for the Health Sciences , 1994 .

[34]  E. E. Gresch.  Genetic Alterations During Colorectal-Tumor Development , 1989 .

[35]  A. Feinberg,et al.  Hypomethylation of ras oncogenes in primary human cancers. , 1983, Biochemical and biophysical research communications.

[36]  Fuchu He,et al.  Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family , 2004, Molecular and Cellular Biochemistry.

[37]  David I. K. Martin,et al.  Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue , 2004, International Journal of Colorectal Disease.

[38]  Xiao-LanHu,et al.  NDRG2 expression and mutation in human liver and pancreatic cancers , 2004 .

[39]  J. Parma,et al.  [Medical genetics service]. , 2002, Revue medicale de Bruxelles.

[40]  M. Waye,et al.  Modulation of the Ca(2+)-activated Cl(-) channel by 14-3-3epsilon. , 2000, Biochemical and biophysical research communications.

[41]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.